MGE Innovation Center Tenants
 
State Journal marks Research Park's birth
November 17, 2008
It was 25 years ago this fall that the UW Board of Regents approved pursuing the creation of University Research Park. That anniversary was marked during the Nov. 5-6 Wisconsin Early Stage Symposium and celebrated in a Nov. 17 editorial in the Wisconsin State Journal.

...........................................

Tech Council board chairman Bugher wins top service award from Marshfield Clinic
November 10, 2008
EAU CLAIRE – Citing his volunteer service to the Marshfield Clinic and the communities it serves, the Marshfield Clinic Heritage Foundation has singled out Mark Bugher for its highest annual award.

...........................................

Kikkoman USA’s announces new research and development laboratory in University Research Park
Sept. 9, 2008
The laboratory, which will join Kikkoman’s global research and development network, will foster increased collaboration between the company and University of Wisconsin-Madison food science researchers
.

...........................................

New ‘urban research park’ offers jolt of electricity to Madison high-tech startups
August 4, 2008
After three decades of almost exponential commercial growth on Madison's west side, the University Research Park (URP) will pursue an opportunity to sink roots downtown with an innovative "urban research park" targeting high-technology entrepreneurs.

...........................................

Return...

Procyon Pharmaceuticals, Inc.

Contact Name:  Terrence P. Clark
Contact Phone:  608-441-2736
Contact Email:  clarktp@procyonpharma.com
Address:  505 S. Rosa, Suite 101
City:  Madison
State:  WI
Zip Code:  53719
Website:  http://www.procyonpharma.com


Categories: 
Pharmaceuticals


Procyon Pharmaceuticals, Inc. is an innovative veterinary pharmaceutical research and development company with a robust, theraputically diverse pipeline of products being developed to meet the needs of veterinarians and pet owners.

Procyon Pharmaceuticals, Inc. is an innovative veterinary pharmaceutical research and development company with a robust, theraputically diverse pipeline of products being developed to meet the needs of veterinarians and pet owners. The first product's development is completed and is under review at the Food and Drug Administration and European Medicines Agency with an expected approval of 2010. Our corporate headquarters are located in historic downtown Pendelton, Indiana with offices in London, UK and strategic partners located across North America, Western Europe, Australia, and New Zealand.